Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Influence of frailty on anticoagulant prescription and clinical outcomes after 1-year follow-up in hospitalised older patients with atrial fibrillation.

Gullón A, Formiga F, Díez-Manglano J, Mostaza JM, Cepeda JM, Pose A, Castiella J, Suárez-Fernández C; NONAVASC study group Vascular Risk Group of the Spanish Society of Internal Medicine.

Intern Emerg Med. 2018 Sep 6. doi: 10.1007/s11739-018-1938-3. [Epub ahead of print]

PMID:
30191535
2.

Factors associated with discontinuing or not starting oral anticoagulant therapy in older hospitalized patients with non-valvular atrial fibrillation.

Díez-Manglano J, Mostaza JM, Pose A, Formiga F, Cepeda JM, Gullón A, Camafort M, Castiella J, Rovira E, Jarauta E, Suárez C.

Geriatr Gerontol Int. 2018 Aug;18(8):1219-1224. doi: 10.1111/ggi.13451. Epub 2018 Jun 13.

PMID:
29897154
3.

Quantitative ELISA sandwich for a new vaccine against avian influenza virus H5N1.

Pose AG, Rodríguez ER, Piñeiro MJ, Montesino R, Sánchez O, Toledo JR.

J Immunol Methods. 2018 Aug;459:70-75. doi: 10.1016/j.jim.2018.05.008. Epub 2018 May 24.

PMID:
29803776
4.

Satisfaction with oral anticoagulants in patients with atrial fibrillation.

Suárez Fernández C, Castilla-Guerra L, Cantero Hinojosa J, Suriñach JM, Acosta de Bilbao F, Tamarit JJ, Diaz Diaz JL, Hernandez JL, Pose A, Montero-Pérez-Barquero M, Roquer J, Gállego J, Vivancos J, Mostaza JM.

Patient Prefer Adherence. 2018 Feb 19;12:267-274. doi: 10.2147/PPA.S152109. eCollection 2018.

5.

Baseline functional status as the strongest predictor of in-hospital mortality in elderly patients with non-valvular atrial fibrillation: Results of the NONAVASC registry.

Gullón A, Formiga F, Camafort M, Mostaza JM, Díez-Manglano J, Cepeda JM, Novo-Veleiro I, Pose A, Suárez Fernández C; NONAVASC study group. Vascular Risk Group of the Spanish Society of Internal Medicine.

Eur J Intern Med. 2018 Jan;47:69-74. doi: 10.1016/j.ejim.2017.09.020. Epub 2017 Sep 24.

PMID:
28954714
6.

Asthma exacerbations: risk factors for hospital readmissions.

Gonzalez-Barcala FJ, Calvo-Alvarez U, Garcia-Sanz MT, Garcia-Couceiro N, Martin-Lancharro P, Pose A, Carreira JM, Moure-Gonzalez JD, Valdes-Cuadrado L, Muñoz X.

Ir J Med Sci. 2018 Feb;187(1):155-161. doi: 10.1007/s11845-017-1633-9. Epub 2017 Jun 7.

PMID:
28593573
7.

Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project.

Pose A, Almenar L, Gavira JJ, López-Granados A, Blasco T, Delgado J, Aramburu O, Rodríguez A, Manzano L, Manito N.

ESC Heart Fail. 2017 May;4(2):130-137. doi: 10.1002/ehf2.12124. Epub 2017 Jan 19.

8.

Hyponatraemia and congestive heart failure refractory to diuretic treatment. Utility of tolvaptan.

Pose A, Almenar L, Manzano L, Gavira JJ, López Granados A, Delgado J, Aramburu O, Arévalo JC, Méndez M, Comín J, Manito N.

Rev Clin Esp. 2017 Oct;217(7):398-404. doi: 10.1016/j.rce.2017.02.013. Epub 2017 Apr 1. English, Spanish.

PMID:
28372784
9.

Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.

Gullón A, Suárez C, Díez-Manglano J, Formiga F, Cepeda JM, Pose A, Camafort M, Castiella J, Rovira E, Mostaza JM; en representación de los investigadores del estudio NONAVASC.

Med Clin (Barc). 2017 Mar 3;148(5):204-210. doi: 10.1016/j.medcli.2016.10.042. Epub 2016 Dec 16. English, Spanish.

PMID:
27993408
10.

[Validation of satisfaction questionnaire ACTS in outpatients with atrial fibrillation treated with oral anticoagulants in Spain. ALADIN Study].

Suárez C, Pose A, Montero-Pérez-Barquero M, Roquer J, Gállego J, Ràfols C, Cazorla D, Vivancos J; en representación del Grupo de Trabajo Comité Científico Estudio ALADIN.

Med Clin (Barc). 2016 Sep 2;147(5):192-198. doi: 10.1016/j.medcli.2016.05.024. Epub 2016 Jul 14. Spanish.

PMID:
27423653
11.

Dual function of the hemagglutinin H5 fused to chicken CD154 in a potential strategy of DIVA against avian influenza disease: preliminary study.

Pose AG, Rodríguez ES, Méndez AC, Gómez JN, Redondo AV, Rodríguez ER, Ramos EM, Gutiérrez AÁ, Moltó MP, Roche DG, Ugalde YS, López AM.

Open Vet J. 2015;5(2):138-47. Epub 2015 Sep 23.

12.

Barriers to Providing Health Education During Primary Care Visits at Community Health Centers: Clinical Staff Insights.

Alicea-Planas J, Pose A, Smith L.

J Community Health. 2016 Apr;41(2):220-5. doi: 10.1007/s10900-015-0085-2.

PMID:
26316006
13.

Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm.

Runkle I, Villabona C, Navarro A, Pose A, Formiga F, Tejedor A, Poch E.

Nefrologia. 2014;34(4):439-50. doi: 10.3265/Nefrologia.pre2014.Apr.12220. English, Spanish.

14.

Symptoms and reason for a medical visit in lung cancer patients.

Gonzalez-Barcala FJ, Falagan JA, Garcia-Prim JM, Valdes L, Carreira JM, Pose A, Canive JC, Anton D, Garcia-Sanz MT, Puga A, Temes E, Lopez-Lopes R.

Acta Med Port. 2014 May-Jun;27(3):318-24. Epub 2014 Jun 30.

15.

Stable lentiviral transformation of CHO cells for the expression of the hemagglutinin H5 of avian influenza virus in suspension culture.

Pose AG, Morell NO, Matos DA, Rodríguez ER, Rodríguez ES, Cordero LR, Moltó MPR, Ramos EMG, Gutiérrez AÁ, Pérez LG, Gómez JN, Redondo AV, Nordelo CB.

Biotechnol Rep (Amst). 2014 May 17;3:108-116. doi: 10.1016/j.btre.2014.05.001. eCollection 2014 Sep.

16.

[The treament of hyponatremia secundary to the syndrome of inappropriate antidiuretic hormone secretion].

Runkle I, Villabona C, Navarro A, Pose A, Formiga F, Tejedor A, Poch E; European Hyponatremia Network.

Med Clin (Barc). 2013 Dec 7;141(11):507.e1-507.e10. doi: 10.1016/j.medcli.2013.09.002. Epub 2013 Oct 26. Spanish.

17.

[Lung cancer in the Pontevedra health area: incidence, clinical presentation and survival].

González-Barcala FJ, Falagán JA, García-Prim JM, Valdés L, Carreira JM, Puga A, García-Sanz MT, Antón D, Canive JC, Pose A, López-López R.

An Sist Sanit Navar. 2013 Sep 6;36(2):217-27. Spanish.

18.

Biosafety evaluation of recombinant protein production in goat mammary gland using adenoviral vectors: preliminary study.

Rodríguez ES, Pose AG, Moltó MP, Espinoza AS, Zamora PA, Pedroso MS.

Biotechnol J. 2012 Aug;7(8):1049-53. doi: 10.1002/biot.201100455. Epub 2012 May 14.

PMID:
22407796
19.

Subunit influenza vaccine candidate based on CD154 fused to HAH5 increases the antibody titers and cellular immune response in chickens.

Pose AG, Gómez JN, Sánchez AV, Redondo AV, Rodríguez ER, Seguí RM, Ramos EM, Moltó MP, Rodríguez ES, Cordero LR, Mallón AR, Nordelo CB.

Vet Microbiol. 2011 Sep 28;152(3-4):328-37. doi: 10.1016/j.vetmic.2011.05.033. Epub 2011 May 25.

PMID:
21680114
20.

Diagnostic value of N-terminal pro-brain natriuretic peptide in pleural effusions of cardiac origin.

Valdés L, José ES, Pose A, González-Barcala FJ, Alvarez-Dobaño JM, Ferreiro L, Anchorena C, Pereyra MF, González-Juanatey JR, Sahn SA.

Arch Bronconeumol. 2011 May;47(5):246-51. doi: 10.1016/j.arbres.2011.02.004. Epub 2011 Apr 6. English, Spanish.

Supplemental Content

Support Center